Continuous Subcutaneous Insulin Infusion Market Research Report by Product (Patch Pumps and Tethered pumps), by Patient Type (Type 1 diabetes and Type 2 diabetes), by End-user, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global

Continuous Subcutaneous Insulin Infusion Market Research Report by Product (Patch Pumps and Tethered pumps), by Patient Type (Type 1 diabetes and Type 2 diabetes), by End-user, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Continuous Subcutaneous Insulin Infusion Market size was estimated at USD 1,947.17 million in 2020 and expected to reach USD 2,173.67 million in 2021, at a CAGR 11.97% to reach USD 3,837.38 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Continuous Subcutaneous Insulin Infusion to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Patch Pumps and Tethered pumps. The Patch Pumps is further studied across Basal, Basal and bolus, and Bous. The Tethered pumps is further studied across Battery, Insulin reservoir and cartridges, and Insulin set insertion devices.

Based on Patient Type, the market was studied across Type 1 diabetes and Type 2 diabetes.

Based on End-user, the market was studied across Homecare, Hospitals, and Laboratory.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Continuous Subcutaneous Insulin Infusion Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Continuous Subcutaneous Insulin Infusion Market, including Apex Medical Corp., Byram Healthcare Centers, Inc., Cellenovo, Cellnovo Group, CeQur SA, Dana Diabecare RS, DEKA Research & Development Corporation, DexCom, Inc., Edgepark, IA Collaborative Holdings, LLC, Kaleido, Medtronic plc, Medtrum Technologies Inc., OpenAPS, Pumps It, Inc., Roche Holding AG, Shanghai Microport Orthopedics, Tandem Diabetes Care, Inc., Tidepool, Valeritus, and Ypsomed Holding.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Subcutaneous Insulin Infusion Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Subcutaneous Insulin Infusion Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Subcutaneous Insulin Infusion Market?
4. What is the competitive strategic window for opportunities in the Global Continuous Subcutaneous Insulin Infusion Market?
5. What are the technology trends and regulatory frameworks in the Global Continuous Subcutaneous Insulin Infusion Market?
6. What is the market share of the leading vendors in the Global Continuous Subcutaneous Insulin Infusion Market?
7. What modes and strategic moves are considered suitable for entering the Global Continuous Subcutaneous Insulin Infusion Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising number of diabetes patients
5.2.2. Growing awareness of advanced insulin delivery devices
5.2.3. Rising healthcare expenditure pertinent to diabetes globally
5.3. Restraints
5.3.1. High cost of devices
5.3.2. Risk of diabetic ketoacidosis (DKA) and skin infection
5.4. Opportunities
5.4.1. Emerging technological advancements such as AI and IoT
5.4.2. Ongoing rise in the number of product launches by market players
5.5. Challenges
5.5.1. Possible risks such as diabetic ketoacidosis and hypoglycemia
6. Continuous Subcutaneous Insulin Infusion Market, by Product
6.1. Introduction
6.2. Patch Pumps
6.2.1. Basal
6.2.2. Basal and bolus
6.2.3. Bous
6.3. Tethered pumps
6.3.1. Battery
6.3.2. Insulin reservoir and cartridges
6.3.3. Insulin set insertion devices
7. Continuous Subcutaneous Insulin Infusion Market, by Patient Type
7.1. Introduction
7.2. Type 1 diabetes
7.3. Type 2 diabetes
8. Continuous Subcutaneous Insulin Infusion Market, by End-user
8.1. Introduction
8.2. Homecare
8.3. Hospitals
8.4. Laboratory
9. Americas Continuous Subcutaneous Insulin Infusion Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Continuous Subcutaneous Insulin Infusion Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Continuous Subcutaneous Insulin Infusion Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Apex Medical Corp.
13.2. Byram Healthcare Centers, Inc.
13.3. Cellenovo
13.4. Cellnovo Group
13.5. CeQur SA
13.6. Dana Diabecare RS
13.7. DEKA Research & Development Corporation
13.8. DexCom, Inc.
13.9. Edgepark
13.10. IA Collaborative Holdings, LLC
13.11. Kaleido
13.12. Medtronic plc
13.13. Medtrum Technologies Inc.
13.14. OpenAPS
13.15. Pumps It, Inc.
13.16. Roche Holding AG
13.17. Shanghai Microport Orthopedics
13.18. Tandem Diabetes Care, Inc.
13.19. Tidepool
13.20. Valeritus
13.21. Ypsomed Holding
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL AND BOLUS, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL AND BOLUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR AND CARTRIDGES, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR AND CARTRIDGES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2020 VS 2026 (%)
FIGURE 24. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2026
FIGURE 26. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 31. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2026
FIGURE 33. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL AND BOLUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR AND CARTRIDGES, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: SCORES
TABLE 51. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: BUSINESS STRATEGY
TABLE 52. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: PRODUCT SATISFACTION
TABLE 53. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: RANKING
TABLE 54. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 55. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: MERGER & ACQUISITION
TABLE 56. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 57. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 58. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: INVESTMENT & FUNDING
TABLE 59. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 60. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook